- Previous Close
256,500.00 - Open
257,000.00 - Bid 255,000.00 x --
- Ask 255,500.00 x --
- Day's Range
253,000.00 - 258,000.00 - 52 Week Range
232,500.00 - 407,500.00 - Volume
22,507 - Avg. Volume
64,694 - Market Cap (intraday)
3.748T - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 12,000.00 (4.68%)
- Ex-Dividend Date Feb 27, 2025
- 1y Target Est
361,461.53
CJ Cheiljedang Corporation engages food and bio businesses in South Korea and internationally. It operates through Food, Biotechnology, FNT, Feed and Care, and Logistics segments. The company offers home meal replacement, meat/fishery processing, seasoning/sauce, sweetener/flour/oil, and seaweed/dessert/snack products. It also provides amino acid, green protein, enzyme, plant nutrition and health, and specialty solution; biomaterials; and microbiomes drug development for genetic based infection disease. In addition, the company taste and beyond products; nutrition solutions; and alternative and cultured proteins. Further, the company engages in the feed, livestock, and fresh meat business; logistics services including transportation, construction, storage, shipping, and discharging. It serves under the bibigo, Hetbahn, Gourmet, Beksul, The Healthy, DASIDA, Haechandle, SPAM, Samho Eomuk, Happy Soy, METIER, Petitzel, Maxbon, Matbam, ALTIVE, Joy of Growing Together, Creeat, TasteNrich, FlavorNrich, AMINATURE, Bestamino, BiomeNrich, and PHACT brand names. CJ Cheiljedang Corporation was founded in 1953 and is based in Seoul, South Korea.
www.cj.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 097950.KS
View More
Performance Overview: 097950.KS
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 097950.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 097950.KS
View MoreValuation Measures
Market Cap
4.11T
Enterprise Value
14.02T
Trailing P/E
27.75
Forward P/E
7.19
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.14
Price/Book (mrq)
0.52
Enterprise Value/Revenue
0.48
Enterprise Value/EBITDA
5.18
Financial Highlights
Profitability and Income Statement
Profit Margin
0.50%
Return on Assets (ttm)
3.25%
Return on Equity (ttm)
3.01%
Revenue (ttm)
29.36T
Net Income Avi to Common (ttm)
148.18B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
1.74T
Total Debt/Equity (mrq)
95.14%
Levered Free Cash Flow (ttm)
444.29B